This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM O. SMITH, M.D.; JAMES F. HAMMARSTEN, M.D.

AMA Arch Intern Med. 1958;102(1):5-9.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The pathologic physiology of certain symptoms in uremic patients remains a mystery. It is generally held that endproducts of metabolism which accumulate in the body lead to depression of the central nervous system, manifested clinically by drowsiness and eventually coma. These symptoms have been reported in patients with renal disease who have been given large doses of magnesium sulfate,¹ and a central nervous system depressant effect of magnesium has been utilized in certain clinical situations for a number of years. The literature on serum levels of magnesium in renal disease is confusing; some studies have shown decreased values, while others have shown markedly increased values.² Furthermore, studies of the relationship of the serum levels of nitrogenous materials, calcium, and potassium to serum magnesium are incomplete.

It is the purpose of this paper to clarify the relationship of serum magnesium to various phases of renal disease and to other . . . [Full Text PDF of this Article]

Author Affiliations
Oklahoma City

From the Medical and Radioisotope Services, Veterans' Administration Hospital, and the Department of Medicine, University of Oklahoma School of Medicine.

Footnotes
Submitted for publication Nov. 4, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?